Your browser doesn't support javascript.
loading
Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry.
Giuliante, Felice; Viganò, Luca; De Rose, Agostino M; Mirza, Darius F; Lapointe, Réal; Kaiser, Gernot; Barroso, Eduardo; Ferrero, Alessandro; Isoniemi, Helena; Lopez-Ben, Santiago; Popescu, Irinel; Ouellet, Jean-Francois; Hubert, Catherine; Regimbeau, Jean-Marc; Lin, Jen-Kou; Skipenko, Oleg G; Ardito, Francesco; Adam, René.
Afiliação
  • Giuliante F; Hepatobiliary Surgery Unit, Foundation "Policlinico Universitario A. Gemelli", IRCCS, Catholic University, Rome, Italy. felice.giuliante@unicatt.it.
  • Viganò L; Division of Hepatobiliary and General Surgery, Department of Surgery, IRCCS - Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • De Rose AM; Hepatobiliary Surgery Unit, Foundation "Policlinico Universitario A. Gemelli", IRCCS, Catholic University, Rome, Italy.
  • Mirza DF; HPB Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Lapointe R; Hepatopancreatobiliary Surgery and Liver Transplantation Service, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
  • Kaiser G; Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, Essen, Germany.
  • Barroso E; HBP and Transplantation Centre, Curry Cabral Hospital, Lisbon Central Hospitals Centre, Lisbon, Portugal.
  • Ferrero A; Department of General and Oncological Surgery, "Umberto I" Mauriziano Hospital, Turin, Italy.
  • Isoniemi H; Department of Liver Surgery and Transplantation, Helsinki University, Helsinki, Finland.
  • Lopez-Ben S; Hepatobiliary and Pancreatic Surgery Unit, Department of Surgery, Dr. Josep Trueta Hospital, IdlBGi, Girona, Spain.
  • Popescu I; Department of Surgery and Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
  • Ouellet JF; CHU de Québec - Université Laval, Quebec City, QC, Canada.
  • Hubert C; Department of HBP Surgery, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Leuven, Belgium.
  • Regimbeau JM; Department of Oncology and Digestive Surgery, CHU Amiens-Picardie, Amiens, France.
  • Lin JK; Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Skipenko OG; Research Center of Surgery, Russian Academy of Medical Science, Moscow, Russia.
  • Ardito F; Hepatobiliary Surgery Unit, Foundation "Policlinico Universitario A. Gemelli", IRCCS, Catholic University, Rome, Italy.
  • Adam R; Department of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France.
Ann Surg Oncol ; 28(13): 8198-8208, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34212254
ABSTRACT

BACKGROUND:

The liver-first approach in patients with synchronous colorectal liver metastases (CRLM) has gained wide consensus but its role is still to be clarified. We aimed to elucidate the outcome of the liver-first approach and to identify patients who benefit at most from this approach.

METHODS:

Patients with synchronous CRLM included in the LiverMetSurvey registry between 2000 and 2017 were considered. Three strategies were analyzed, i.e. liver-first approach, colorectal resection followed by liver resection (primary-first), and simultaneous resection, and three groups of patients were analyzed, i.e. solitary metastasis, multiple unilobar CRLM, and multiple bilobar CRLM. In each group, patients from the three strategy groups were matched by propensity score analysis.

RESULTS:

Overall, 7360 patients were analyzed 4415 primary-first, 552 liver-first, and 2393 simultaneous resections. Compared with the other groups, the liver-first group had more rectal tumors (58.0% vs. 31.2%) and higher hepatic tumor burden (more than three CRLMs 34.8% vs. 24.0%; size > 50 mm 35.6% vs. 22.8%; p < 0.001). In patients with solitary and multiple unilobar CRLM, survival was similar regardless of treatment strategy, whereas in patients with multiple bilobar metastases, the liver-first approach was an independent positive prognostic factor, both in unmatched patients (3-year survival 65.9% vs. primary-first 60.4% hazard ratio [HR] 1.321, p = 0.031; vs. simultaneous resections 54.4% HR 1.624, p < 0.001) and after propensity score matching (vs. primary-first HR 1.667, p = 0.017; vs. simultaneous resections HR 2.278, p = 0.003).

CONCLUSION:

In patients with synchronous CRLM, the surgical strategy should be decided according to the hepatic tumor burden. In the presence of multiple bilobar CRLM, the liver-first approach is associated with longer survival than the alternative approaches and should be evaluated as standard.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article